Targeting the TRIM21-PD-1 axis potentiates immune checkpoint blockade and CAR-T cell therapy
Jie Shi(Wuhan University), Jinfang Zhang(Wuhan University)
Cited by 15
Related Papers
USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy
|Nature Communications|2022|150
Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy
|Cell chemical biology|2023|86
ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy
|Nature Communications|2023|75